Skip to ContentSkip to Navigation
About us Faculty of Science and Engineering Our Research GRIP Nanomedicine and Drug Targeting Publications

Publications 2004

Scientific Publications 2004
  1. Kapojos JJ, Poelstra K, Borghuis T, Banas B, Bakker W W.  Regulation of plasma hemopexin activity by stimulated endothelial or mesangial cells. Nephron Physiology, 2004; 96, 1-10 DOI

  2. de Kanter R, Monshouwer, M, Draaisma AL, de Jager H, de Graaf IAM, Proost JH, Meijer DKF, Groothuis GMM.  Prediction of whole-body metabolic clearance of drugs through the combined use of slices from rat liver, lung, kidney, small intestine and colon. Xenobiotica, 2004; 34, 229-241 DOI

  3. van Zanten J, Doornbos-van der Meer B, Audouy S, Kok RJ, de Leij LFMA.  A nonviral carrier for targeted gene delivery to tumor cells. Cancer Gene Therapy, 2004; 11, 156-164 DOI

  4. Verweij WR, Bentala H, Huizinga-van der Vlag A, van Loenen-Weemaes AM,  Kooi K, Meijer DKF, Poelstra K.   Protection against an Escherichia coli-induced sepsis by alkaline phosphatase in mice. Shock, 2004; 22, 174-179 DOI

  5. Schoemaker MH, Conde de la Rosa L, Buist-Homan M, Vrenken TE, Havinga R,  Poelstra K, Haisma HJ, Jansen PLM, Moshage H.    Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology, 2004; 39, 1563-1573 DOI

  6. Elferink MGL, Olinga P, Draaisma AL, Merema MT, Faber KN, Slooff MJH, Meijer DKF, Groothuis GMM.   LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am. J. Physiol. Gastrointest. Liver Physiol. 2004; 287, G1008-G101 DOI

  7. Ogawara K, Rots MG, Kok RJ, Moorlag HE, Van Loenen AM, Meijer DKF, Haisma HJ,  Molema G.   A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo. Hum. Gene Ther., 2004; 15, 433-443 DOI

  8. Hui AY, Dannenberg AJ, Sung JJJ, Subbaramaiah K, Du B, Olinga P, Friedman SL. Prostaglandin E(2) inhibits transforming growth factor beta1-mediated induction of collagen alpha(1)(I) in hepatic stellate cells. J. Hepatol., 2004; 41, 251-258 DOI

  9. Beljaars L, van der Strate BWA, Bakker HI, Reker-Smit C, van Loenen-Weemaes AM, Wiegmans FC, Harmsen MC, Molema G, Meijer DKF.  Inhibition of cytomegalovirus infection by lactoferrin in vitro and vivo. Antiviral Research, 2004; 63, 197-208 DOI

  10. Schraa AJ, Kok RJ, Botter SM, Withoff S, Meijer DKF, De Leij LFMH, Molema G.  RGD-modified anti-CD3 antibodies redirect cytolytic capacity of cytotoxic T lymphocytes toward alpha(v)beta(3)-expressing endothelial cells. Int. J. Cancer, 2004; 112, 279-285 DOI

  11. Yan X, Poelstra K, Scherphof GL, Kamps JAAM.  A role for scavenger receptor B-I in selective transfer of rhodamine-PE from liposomes to cells. Biochem Biophys Res Commun 2004; 325(3), 908-914 DOI

  12. Rachmawati H, Beljaars L, Reker-Smit C, van Loenen-Weemaes AM, Hagens WI, Meijer DKF, Poelstra K.  Pharmacokinetic and biodistribution profile of recombinant human interleukin-10 following intravenous administration in rats with extensive liver fibrosis. Pharm Res 2004; 21(11), 2072-2078 DOI

  13. 't Hart NA, van der Plaats A,  Leuvenink HGD, Wiersema-Buist J, Olinga P, van Luyn MJA, Verkerke GJ, Rakhorst G, Ploeg RJ.  Initial blood washout during organ procurement determines liver injury and function after preservation and reperfusion. Am J Transplant 2004; 4(11), 1836-1844 DOI

  14. Vickers AEM, Saulnier M, Cruz E, Merema MT, Rose K, Bentley P, Olinga P.  Organ slice viability extended for pathway characterization: an in vitro model to investigate fibrosis. Toxicol Sci, 2004; 82(2), 534-544 DOI

  15. Yan X, Morselt HWM, Scherphof GL, Poelstra K, Kamps JAAM. The role of beta 2 -glycoprotein I in liposome-hepatocyte interaction. Biochimica et Biophysica Acta 2004; 1667, 208-214 DOI

  16. Hoekstra M, Haagsma C, Neef C, Proost J, Knuif A, van de Laar M. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis. The Journal of Rheumatology, 2004; 31(4)645-648 DOI

  17. Groninger E, Proost JH, De Graaf SSN. Pharmacokinetic studies in children with cancer. Critical Reviews in Oncology/Hematology, 2004; 52(3):173-197 DOI

  18. Deneer VHM, Lie-A-Huen L, Kingma JH, Proost JH, Gossen SA, Stuurman A, Uytdehaag GMM, Dunselman PHJM, Brouwers JRBJ. Absorption kinetics and pharmacodynamics of two oral dosage forms of flecainide in patients with an episode of paroxysmal atrial fibrillation. European Journal of Clinical Pharmacology, 2004; 60(10):693-701 DOI

  19. Windt WAKM, Prakash J, Kok RJ, Moolenaar F, Kluppel CA, de Zeeuw D, van Dokkum RPE, Henning RH. Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis. Journal of the Renin-Angiotensin-Aldosterone System, 2004; 5(4):197-202

  20. Bartsch M, Weeke-Klimp AH, Hoenselaar EPD, Stuart MCA, Meijer DKF, Scherphof GL, Kamps JAAM. Stabilized lipid coated lipoplexes for the delivery of antisense oligonucleotides to liver endothelial cells in vitro and in vivo. Journal of Drug Targeting, 2004; 12(9-10):613-621 DOI

  21. Kapojos JJ, van den Berg A, Borghuis T, Banas B, Huitema S, Poelstra K, Bakker WW. Enhanced ecto-apyrase activity of stimulated endothelial or mesangial cells is downregulated by glucocorticoids in vitro. European Journal of Pharmacology, 2004; 501(1-3):191-198 DOI

Chapters in books in 2004

  1. Rachmawati H, Poelstra K, Beljaars L. The use of cytokines and modified cytokines as therapeutic agents: Present state and future perspective. In book: Recent research development in immunology. Research Signpost, Kerala, India. Ed.: SG Pandalai. 6(2004): ISBN:81-7736-206-2. p.191-217.

Professional Publications in 2004

  1. Groothuis GMM. De lever als transporteur. Pharmaceutisch Weekblad 139[5], 163-168. 2004.

  2. de Kerkhof EG. AIO, een interessante mogelijkheid. Foliolum 17[5], 30-31. 2004.

  3. van Opstal M, Poelstra K.  Driving forces in drug targeting. Klaas Poelstra geïnterviewd door M. van Opstal. Conceptuur 40, 2004; 12-13

Last modified:04 February 2020 12.38 p.m.
View this page in: Nederlands